Position in TAK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,679,687
-$378,372 QoQ
Shares Held
167,167
+1.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#61
of 376 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Carrera Capital Advisors holds $7,397,468 across 2 Drug Manufacturers - Specialty & Generic names. TAK ranks #2 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
90,034 | $4,717,781 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
167,167 | $2,679,687 |
All Filings in TAK
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,679,687 | 167,167 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,058,059 | 165,122 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,499,996 | 160,359 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,204,754 | 150,598 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,151,181 | 139,145 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||